SOURCE: Medify Solutions Ltd

December 04, 2006 11:41 ET

MedifyRemote™ Expanded NHS Usage

STAFFORD, ENGLAND -- (MARKET WIRE) -- December 4, 2006 --Medify Solutions (PINKSHEETS: MDFY) is delighted to today announce the final sign-off of its NHS approval phase. A statement issued today from Doncaster NHS PCT, site of the successful MedifyRemote™ project, confirms the news.

"We are delighted to confirm the Executive have today signed off the approval of MedifyRemote™ for expanded use with NHS patient identifiable data. As a non-commercial organisation, Doncaster NHS PCT have requested that all future communications regarding MedifyRemote™ are managed by our NHS partner Medify Solutions Limited."

The news has a huge impact for MedifyRemote™ and its parent company, Staffordshire-based Medify Solutions Limited, the first company globally to reach the market with a secure mobile access for patient notes.

With significant interest gained around the product, and 9 NHS Primary Care Trusts (PCT) actively involved in ordering the product ahead of today's announcement, the news from Doncaster effectively enables the system for use throughout the NHS. With a potential half a million clinical users within the National Health Service, MedifyRemote™ is truly at the cutting edge of eHealthcare and is set to revolutionise patient information access throughout the health service.

This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

Contact Information